Moat Biotechnology
Oklahoma City
About Moat Biotechnology
Based on the SC-AdVax platform that was exclusively licensed by the Mayo Clinic, Moat Biotechnology is a biopharmaceutical firm in the clinical development stage that is dedicated to the development of innovative intranasal and oral vaccines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $8.0M
- Last round: Undisclosed (Oct 2025)
- Phone: 405-271-1469
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/moat-biotechnology-52392 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.